Asterias Biotherapeutics, Inc. Banking Regulation, Total Capital, Actual
Asterias Biotherapeutics, Inc. had Banking Regulation, Total Capital, Actual of $27.00 million as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes
us-gaap:Capital · last filed 2016-11-14
- 2016-09-30: Banking Regulation, Total Capital, Actual $27.00M.
- 2016-06-30: Banking Regulation, Total Capital, Actual $25.00M.
| Period end | Banking Regulation, Total Capital, Actual |
|---|---|
| 2016-09-30 | $27.00M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $25.00M 10-Q · filed 2016-08-15 |